Literature DB >> 4604153

Bioavailability of drugs (second of two parts).

J Koch-Weser.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4604153     DOI: 10.1056/NEJM197409052911005

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Physiological modeling to understand the impact of enzymes and transporters on drug and metabolite data and bioavailability estimates.

Authors:  Huadong Sun; K Sandy Pang
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

2.  Dosage, compliance and bioavailability in perspective.

Authors:  P Biron
Journal:  Can Med Assoc J       Date:  1976-07-17       Impact factor: 8.262

3.  Determinants of response to frusemide in normal subjects.

Authors:  R A Branch; C J Roberts; M Homeida; D Levine
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

4.  Generic prescribing--a change of habit.

Authors:  A Hill
Journal:  J R Coll Gen Pract       Date:  1985-02

5.  Plasma levels of d-amphetamine in hyperactive children. Serial behavior and motor responses.

Authors:  G L Brown; R D Hunt; M H Ebert; W E Bunney; I J Kopin
Journal:  Psychopharmacology (Berl)       Date:  1979-04-11       Impact factor: 4.530

6.  Bioavailability of digoxin tablets in healthy volunteers.

Authors:  C H Lee; Y J Park; C D Sands; D W Jones; J M Trang
Journal:  Arch Pharm Res       Date:  1994-04       Impact factor: 4.946

7.  The bioavailability of phenytoin.

Authors:  R Gugler; W Fröscher; M Eichelbaum; G Hildenbrand
Journal:  J Neurol       Date:  1977-10-07       Impact factor: 4.849

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.